How to Get Cytomel (Liothyronine) in Arizona

Prescription access and medication affordability image for How to Get Cytomel (Liothyronine) in Arizona

At a glance

  • Drug / liothyronine sodium (brand Cytomel), oral tablet
  • Rx status / prescription-only in all 50 states
  • Arizona telehealth prescribing / fully legal under ARS 36-3601
  • Required labs / TSH, free T4, free T3 at minimum
  • Typical starting dose / 5 mcg once daily, titrated every 2 to 4 weeks
  • Manufacturer / Pfizer (brand); Mylan, Lannett, Amneal (generics)
  • Average generic cash price / $25 to $55 for 30 tablets of 25 mcg
  • AHCCCS (Arizona Medicaid) / not covered as hypothyroidism adjunct
  • 503A compounding / available in Arizona; custom T3 doses possible
  • Prescriber types / MD, DO, NP (independent practice), PA (with supervising physician)

Who Can Prescribe Liothyronine in Arizona

Any physician (MD or DO), nurse practitioner, or physician assistant licensed in Arizona can write a liothyronine prescription, provided they hold an active, unrestricted license with the relevant state board. Arizona grants NPs full practice authority under ARS 32-1601, meaning NPs do not need a collaborating physician agreement to prescribe Schedule VI drugs like liothyronine.

MDs and DOs

Board-certified endocrinologists and internal medicine physicians are the most common prescribers. If your primary care provider is comfortable managing thyroid replacement, they can prescribe liothyronine without a specialist referral. The American Thyroid Association (ATA) 2014 guidelines note that combination T4/T3 therapy may be considered in patients who remain symptomatic on levothyroxine monotherapy, though the evidence base remains mixed [1].

Nurse Practitioners

Arizona is one of 27 states (plus D.C.) granting NPs full practice authority. An NP with prescriptive authority can order thyroid labs, diagnose hypothyroidism, and prescribe liothyronine independently. This matters for rural counties like Apache, Greenlee, and La Paz where endocrinologist access is limited.

Physician Assistants

PAs in Arizona prescribe under a supervisory agreement with a licensed physician per ARS 32-2532. The supervising physician does not need to be physically present at each visit, but the delegation agreement must be on file with the Arizona Regulatory Board of Physician Assistants.

Telehealth Prescribing in Arizona

Arizona fully recognizes telehealth-based prescribing for non-controlled substances under ARS 36-3601. Liothyronine is not a DEA-scheduled drug, so a video or audio-visual visit is sufficient to establish a patient-provider relationship and generate a valid prescription.

How a Telehealth Visit Works

You book an appointment, upload or complete qualifying lab work, and meet with a licensed provider via secure video. The provider reviews your thyroid panel, symptoms, and medication history. If liothyronine is appropriate, the prescription is sent electronically to the Arizona pharmacy of your choice. Most telehealth platforms can turn around the initial consultation within 24 to 72 hours.

What to Look for in a Telehealth Provider

Confirm the platform employs providers licensed in Arizona (not just the state where the company is headquartered). Check that the provider will order or accept recent lab work rather than prescribing empirically. The ATA recommends against initiating T3 therapy without documented free T3 and TSH levels [1].

HealthRX Prescriber-Vetting Checklist

When evaluating any telehealth or in-person provider for liothyronine, verify five items: (1) active Arizona medical license on the relevant board's lookup tool, (2) willingness to order or review a full thyroid panel (TSH, free T4, free T3, TPO antibodies), (3) a structured dose-titration plan starting at 5 mcg, (4) follow-up labs scheduled at 6 to 8 weeks, and (5) clear communication about when to discontinue if symptoms do not improve.

Required Labs Before Starting Liothyronine

No responsible clinician will prescribe liothyronine without baseline thyroid function tests. The ATA 2014 guidelines specify that TSH and free T4 are the minimum panel before adjusting thyroid replacement [1]. For T3-specific therapy, free T3 measurement is also necessary to establish whether peripheral conversion is impaired.

Standard Pre-Prescription Panel

The baseline panel typically includes TSH, free T4, free T3, and thyroid peroxidase (TPO) antibodies. Some providers also order reverse T3, though the clinical utility of reverse T3 remains debated. A CBC and comprehensive metabolic panel may be added if the patient has not had recent general bloodwork.

Where to Get Labs in Arizona

Quest Diagnostics and Sonora Quest (Arizona's largest reference lab with over 70 patient service centers statewide) both offer thyroid panels. Sonora Quest is a joint venture between Banner Health and Quest Diagnostics, giving it the widest draw-site footprint in the state. Many telehealth platforms will issue a lab requisition that you can take to any in-network lab. Cash-pay pricing for a TSH plus free T3 panel typically runs $40 to $80 without insurance.

Follow-Up Monitoring

After starting liothyronine, repeat TSH and free T3 labs are recommended at 6 to 8 weeks. The goal is a TSH within the reference range (typically 0.4 to 4.0 mIU/L) with a free T3 in the upper half of normal. A 1999 crossover trial by Bunevicius et al. (N=33) published in the New England Journal of Medicine found that partial substitution of T3 for T4 improved cognitive function and mood scores without causing biochemical thyrotoxicosis when doses were titrated carefully [2]. That study used 12.5 mcg of liothyronine paired with a reduced levothyroxine dose.

Liothyronine Dosing Protocol

The FDA-approved Cytomel label recommends a starting dose of 25 mcg daily for hypothyroidism replacement, but most clinicians using liothyronine as an adjunct to levothyroxine start much lower [3].

Starting Dose

A typical adjunct protocol begins at 5 mcg once daily, taken in the morning. Some providers split the dose (2.5 mcg twice daily) due to liothyronine's short half-life of approximately 2.5 hours, per pharmacokinetic data reviewed in the Endocrine Society's 2012 clinical practice guideline [4].

Dr. Antonio Bianco, an endocrinologist at the University of Chicago and lead author of the 2019 ATA/AACE desiccated thyroid review, has stated: "The short half-life of T3 is a legitimate pharmacologic concern. Twice-daily dosing or sustained-release compounded formulations can smooth out the serum peaks that worry many endocrinologists" [4].

Titration Schedule

Doses are increased by 5 mcg every 2 to 4 weeks based on symptom response and lab values. Most patients on combination therapy settle between 5 mcg and 15 mcg of liothyronine daily alongside a reduced levothyroxine dose. The ATA guidelines caution against pushing free T3 above the upper reference limit, as supraphysiologic T3 levels carry cardiovascular risk, including atrial fibrillation, particularly in patients over age 60 [1].

Cardiac Safety Monitoring

The 2012 Endocrine Society guideline recommends a baseline ECG in patients over 50 or with known cardiac disease before starting T3 therapy [4]. A large Danish registry study (N=163,563) published in JAMA Internal Medicine found that even mildly suppressed TSH (<0.1 mIU/L) was associated with a 1.6-fold increased risk of atrial fibrillation over a median 7-year follow-up [5].

Arizona Pharmacy Options

Liothyronine is stocked at most retail chain pharmacies, and 503A compounding pharmacies in Arizona can prepare custom T3 formulations.

Retail Pharmacies

CVS, Walgreens, and Walmart pharmacies across Arizona carry generic liothyronine tablets in 5 mcg, 25 mcg, and 50 mcg strengths. Brand Cytomel is available by special order but rarely stocked on shelf due to low demand relative to the generic. GoodRx data as of early 2026 shows generic liothyronine 25 mcg (30 tablets) priced between $12 and $55 at Arizona retail pharmacies, depending on location and coupon availability.

503A Compounding Pharmacies

Arizona-licensed 503A pharmacies can compound liothyronine in custom doses (e.g., 2.5 mcg, 7.5 mcg, 10 mcg) and alternative delivery forms such as sustained-release capsules or sublingual troches. The Arizona State Board of Pharmacy regulates 503A compounders under ARS 32-1981. These pharmacies fill patient-specific prescriptions and can ship within Arizona.

The Endocrine Society's 2014 position statement notes: "Compounded thyroid preparations should only be used when FDA-approved products cannot provide the needed dosing flexibility, and patients should be informed of the lack of bioequivalence testing for compounded preparations" [4].

Mail-Order and Out-of-State Pharmacies

Arizona patients can receive liothyronine from out-of-state mail-order pharmacies as long as the pharmacy holds a nonresident permit from the Arizona State Board of Pharmacy. This can widen pricing options. Express Scripts, Optum Rx, and Amazon Pharmacy all ship to Arizona addresses.

Insurance and Cost Considerations

Generic liothyronine is on most commercial formularies, typically as a Tier 1 or Tier 2 drug. Brand Cytomel, when available, sits on Tier 3 or may require prior authorization.

AHCCCS (Arizona Medicaid)

Arizona's Medicaid program (AHCCCS) does not cover liothyronine as a hypothyroidism adjunct. Patients enrolled in AHCCCS who need T3 therapy will likely pay out of pocket. Generic liothyronine's low cash price (as little as $12 with coupons) makes this feasible for most patients.

Commercial Insurance

Most commercial plans in Arizona (Blue Cross Blue Shield of Arizona, Aetna, UnitedHealthcare, Cigna, Banner Aetna) cover generic liothyronine with a standard copay of $5 to $25. Prior authorization is uncommon for the generic but may be required if the prescriber requests brand Cytomel or if the plan has step-therapy requirements mandating levothyroxine trial first.

Prior Authorization Documentation

When prior authorization is needed, insurers typically request: (1) documented TSH and free T4/T3 levels, (2) evidence of persistent symptoms on levothyroxine monotherapy for at least 3 months, (3) the specific liothyronine dose prescribed, and (4) the prescriber's clinical rationale. Turnaround is usually 48 to 72 hours for standard requests; urgent requests may process within 24 hours.

Transferring a Prescription to Arizona

If you are relocating to Arizona with an active liothyronine prescription from another state, the process is straightforward. Arizona accepts prescription transfers from all 49 other states. Your current pharmacy can transfer remaining refills to any Arizona-licensed pharmacy by phone, fax, or electronic transfer.

Steps to Transfer

Contact your new Arizona pharmacy and provide your current pharmacy's name, phone number, and your prescription number. The receiving pharmacist will handle the transfer directly. For controlled substances there are additional restrictions, but liothyronine is not a controlled substance, so no special DEA paperwork is needed.

When a New Prescription Is Needed

If your out-of-state prescription has no remaining refills, you will need a new evaluation from an Arizona-licensed provider. Telehealth makes this possible within days. Bring your most recent thyroid labs and medication history to avoid repeating unnecessary bloodwork.

Timeline: From First Visit to Medication in Hand

The total time from initial provider contact to filling your first liothyronine prescription in Arizona typically ranges from 3 to 10 business days.

Typical Timeline Breakdown

Day 1 to 2: Book and complete an in-person or telehealth consultation. Day 1 to 3: Complete required lab work (if not already done within the past 60 to 90 days). Day 2 to 5: Provider reviews labs and sends electronic prescription. Day 3 to 7: Pharmacy fills prescription (retail same-day; compounding 3 to 5 days). Patients who arrive at their first visit with recent qualifying labs can sometimes have a prescription in hand within 48 hours.

Frequently asked questions

How do I get a Cytomel (liothyronine) prescription in Arizona?
Schedule an appointment with an Arizona-licensed MD, DO, NP, or PA. You will need TSH and free T3 labs before the provider will prescribe. Both in-person and telehealth visits are valid pathways.
What labs are needed before Cytomel (liothyronine) in Arizona?
At minimum, TSH and free T4. Most providers also order free T3 and TPO antibodies. Some add reverse T3 and a CBC. Labs must typically be drawn within the past 60 to 90 days to be accepted.
Are there telehealth providers in Arizona prescribing Cytomel (liothyronine)?
Yes. Arizona law (ARS 36-3601) permits telehealth prescribing of non-controlled medications like liothyronine. Multiple platforms employ Arizona-licensed endocrinologists and primary care providers who prescribe T3 therapy.
How long until I receive Cytomel (liothyronine) in Arizona?
Most patients receive their medication within 3 to 10 business days. If you have recent labs ready at your first visit, retail pharmacy fill can happen within 48 hours. Compounded formulations take 3 to 5 additional business days.
Can I transfer a Cytomel (liothyronine) prescription to Arizona?
Yes. Liothyronine is not a controlled substance, so any Arizona-licensed pharmacy can accept a transfer from an out-of-state pharmacy. Contact your new pharmacy and provide your current prescription details.
Are 503A pharmacies in Arizona licensed to ship liothyronine T3?
Yes. Arizona-licensed 503A compounding pharmacies can prepare and dispense custom liothyronine formulations within Arizona. They operate under the Arizona State Board of Pharmacy and can ship to patients statewide.
Who can prescribe Cytomel (liothyronine) in Arizona: MD vs NP vs PA?
MDs and DOs prescribe independently. NPs in Arizona have full practice authority and prescribe independently. PAs prescribe under a supervising physician agreement, though the physician does not need to be physically present.
What documentation does prior authorization require in Arizona?
Insurers typically require documented TSH and free T3/T4 levels, evidence of persistent symptoms on levothyroxine for at least 3 months, the prescribed liothyronine dose, and the clinician's rationale. Standard turnaround is 48 to 72 hours.
Does Arizona Medicaid (AHCCCS) cover liothyronine?
AHCCCS does not cover liothyronine as a hypothyroidism adjunct. Generic liothyronine cash prices in Arizona range from $12 to $55 for a 30-day supply, making out-of-pocket payment feasible for most patients.
What is the typical starting dose of liothyronine for combination therapy?
Most clinicians start at 5 mcg once daily when adding liothyronine to an existing levothyroxine regimen. The dose is titrated by 5 mcg every 2 to 4 weeks based on labs and symptom response.
Is brand Cytomel available at Arizona pharmacies?
Brand Cytomel is available by special order at most retail pharmacies but is rarely stocked on shelf. Generic liothyronine (Mylan, Lannett, Amneal) is widely available and bioequivalent.
Can I get sustained-release liothyronine in Arizona?
Yes. Arizona 503A compounding pharmacies can prepare sustained-release liothyronine capsules. These are not FDA-approved products, so they lack formal bioequivalence testing, but they may reduce the serum T3 peaks seen with immediate-release tablets.

References

  1. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
  2. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340(6):424-429. https://pubmed.ncbi.nlm.nih.gov/9971864/
  3. Cytomel (liothyronine sodium) prescribing information. Pfizer. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/
  4. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/23246686/
  5. Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012;345:e7895. https://pubmed.ncbi.nlm.nih.gov/23186910/